The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activationCorinna McCarthy, Vincenzo Cerundolo, Dawn Shepherd et al.|The Journal of Experimental Medicine|2007Cited by 220
MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem CellsDina Stroopinsky, David Avigan, Katarina Luptakova et al.|Cancer Research|2013Cited by 54
Muc1 Inhibition Reverses the Poor Immunogenicity of Leukemia Stem Cells Rendering Them Susceptible to ImmunotherapyJacalyn Rosenblatt, David Avigan, Dina Stroopinsky et al.|Transplantation and Cellular Therapy|2012Cited by 2
MUC1 Inhibition Reverses the Poor Immunogenicity of Leukemia Stem Cells Rendering Them Susceptible to ImmunotherapyDina Stroopinsky, David Avigan, Jacalyn Rosenblatt et al.|Blood|2011Cited by 1
Supplementary Figure Legends from MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem CellsDina Stroopinsky, David Avigan, Jacalyn Rosenblatt et al.|Unknown|2023Cited by 0